Back
Cidara Therapeutics Stock Price Chart

Hurry! Enter these 2 trades by EOD Tuesday
Click here to access your first two trades.
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$63.02
Seasonality Move:
2.01%
7 Day Trial
ALL ACCESS PASS
$
7

Trade Alert: Your First Two (Money Doubling?) Trades
Claim your first two trades here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
Cidara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.11 | Sell |
20-day SMA: | 61.15 | Buy |
50-day SMA: | 46.89 | Buy |
200-day SMA: | 27.08 | Buy |
8-day EMA: | 58.14 | Buy |
20-day EMA: | 41.46 | Buy |
50-day EMA: | 22.13 | Buy |
200-day EMA: | 6.48 | Buy |
Cidara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.72 | Buy |
Relative Strength Index (14 RSI): | 66.1 | Buy |
Chaikin Money Flow: | -71329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.74 - 63.84) | Buy |
Bollinger Bands (100): | (16.87 - 51.01) | Buy |
Cidara Therapeutics Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 62.00 while CDTX 8-day simple moving average is 62.11, which is a Sell signal.
-
The stock price of CDTX is 62.00 while Cidara Therapeutics 20-day SMA is 61.15, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 46.89 while CDTX share price is 62.00, making it a Buy technically.
-
CDTX stock price is 62.00 and Cidara Therapeutics 200-day simple moving average is 27.08, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
1.6B
Price in USD:
62.00
Share Volume:
303.6K
Cidara Therapeutics 52-Week Range
52-Week High:
66.95
52-Week Low:
10.14
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 62.00 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 62.00 while CDTX 8-day exponential moving average is 58.14, which is a Buy signal.
-
The stock price of CDTX is 62.00 while Cidara Therapeutics 20-day EMA is 41.46, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 22.13 while CDTX share price is 62.00, making it a Buy technically.
-
CDTX stock price is 62.00 and Cidara Therapeutics 200-day simple moving average is 6.48, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 16.72, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 66.1, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is (54.74 - 63.84), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is (16.87 - 51.01), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.